Nutrition in gastrointestinal illness:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Philadelphia [u.a.]
Saunders
2007
|
| Schriftenreihe: | Gastroenterology clinics of North America
36,1 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XIII, 218 S. Ill., graph. Darst. |
| ISBN: | 1416039112 9781416039112 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV022468894 | ||
| 003 | DE-604 | ||
| 005 | 20150113 | ||
| 007 | t | ||
| 008 | 070618s2007 ad|| |||| 00||| eng d | ||
| 020 | |a 1416039112 |9 1-4160-3911-2 | ||
| 020 | |a 9781416039112 |9 978-1-4160-3911-2 | ||
| 035 | |a (OCoLC)145743502 | ||
| 035 | |a (DE-599)HBZHT015139161 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-91 |a DE-19 |a DE-29 | ||
| 082 | 0 | |a 616.330654 |2 22 | |
| 245 | 1 | 0 | |a Nutrition in gastrointestinal illness |c guest ed. Alan L. Buchman |
| 264 | 1 | |a Philadelphia [u.a.] |b Saunders |c 2007 | |
| 300 | |a XIII, 218 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Gastroenterology clinics of North America |v 36,1 | |
| 650 | 4 | |a Gastrointestinal Diseases | |
| 650 | 4 | |a Gastrointestinal Diseases |x diet therapy | |
| 650 | 4 | |a Gastrointestinal system |x Diseases |x Nutritional aspects | |
| 650 | 4 | |a Nutrition Disorders | |
| 700 | 1 | |a Buchman, Alan L. |d 1960- |e Sonstige |0 (DE-588)137986106 |4 oth | |
| 830 | 0 | |a Gastroenterology clinics of North America |v 36,1 |w (DE-604)BV000613725 |9 36,1 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015676419&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-015676419 | ||
Datensatz im Suchindex
| _version_ | 1804136555224236032 |
|---|---|
| adam_text | Elsevier BEMsfiHallES«3aME^^^^^^^^^^^^^^^^^^^^B
sAUNDERs HflHHMNMBHiHMHMIH^^^H^^^^Hil^l^HliH^^^^Hii^H
Nutrition in Gastrointestinal Illness
CONTENTS VOLUME 36 « NUMBER 1 » MARCH 2007
Preface xi
Alan L. Buchman
Nutritional Assessment 1
Mark H. DeLegge and Luke M. Drake
Hospital based malnutrition continues to be an important comorbidity
affecting clinical outcomes. Knowledge of performing an appropriate
nutrition assessment and implementing a rational nutrition therapy
should be part of any patient s hospital plan of care. Familiarity with
nutrition assessment scoring systems and nutrition assessment tools
should be part of any gastroenteroiogist s expertise. Assessment of
a patient s caloric and protein needs should be part of any hospital
patient s clinical evaluation.
Complications of Parenteral Nutrition 23
Andrew Ukleja and Michelle M. Romano
Parenteral nutrition plays a vital role for patients with intestinal failure
and those who are unable to maintain oral or enterai nutrition alone.
Parenteral nutrition has been shown to improve clinical outcome in
patients with malnutrition and intestinal tract dysfunction. The use of
parenteral nutrition is not without risk of serious complications.
Parenteral nutrition complications can be divided into mechanical
related to vascular access, septic, and metabolic. This article provides
a review on the short and long term complications of parenteral
nutrition and their management.
Prebiotics, Probiotics, and Dietary Fiber
in Gastrointestinal Disease 47
Jacqueline Park and Martin H. Floch
Microecology of the gastrointestinal tract is the physiologic basis for the
effect of dietary fiber, prebiotics and probiotics on the host. The ecology
consists of the gastrointestinal tract, primarily the intestines, the foods
that are fed into the tract, and the flora living within. Within this
ecology, normal flora and probiotics, ferment dietary fiber and
prebiotics to produce short chain fatty acids and substances that are
absorbed and effect the host at the intestinal level and systemically. In
CONTENTS continued
this review, we will discuss the effects of prebiotics, probiotics and
dietary fiber in gastrointestinal disorders and diseases.
Nutrition Support in Acute Pancreatitis 65
Stephen A. McClave
The benefit of early enterai nutrition (EN) for the disease process and
for patient outcome in severe acute pancreatitis is dramatic. A narrow
window of opportunity exists during which there is potential for EN to
decrease disease severity and reduce overall complications. Most
patients with severe pancreatitis tolerate enterai feeds. Any signs of
symptom exacerbation or increasing inflammation in response to EN
may be ameliorated by subtle adjustments in the feeding strategy. In
this manner, provision of EN represents primary therapy in the
management of the patient with acute pancreatitis and is emerging as
the gold standard of therapy in nutrition support for this disease
process.
Food Allergies and Eosinophilic Gastrointestinal Illness 75
Nirmala Gonsalves
Eosinophilic gastrointestinal disorders are characterized by eosinophilic
infiltration and inflammation of the gastrointestinal tract in the absence
of previously identified causes of eosinophilia, such as parasitic
infections, malignancy, collagen vascular diseases, drug sensitivities,
and inflammatory bowel disease. These disorders include eosinophilic
esophagitis, eosinophilic gastroenteritis, eosinophilic enteritis, and
eosinophilic colitis. This article focuses mainly on eosinophilic
esophagitis and eosinophilic gastroenteritis.
Nutritional Deficiencies in Celiac Disease 93
Susan H. Barton, Darlene G. Kelly, and Joseph A. Murray
Celiac disease is characterized by small bowel enteropathy, precipitated
in genetically susceptible individuals by the ingestion of gluten, which
is a term used to encompass the storage proteins of wheat, rye, and
barley. Although the intestine heals with removal of gluten from die
diet, the intolerance is permanent and the damage recurs if gluten is
reintroduced. This damage causes a wide variety of consequence
including maldigestion and malabsorption, resulting in the character¬
istic, aldiough not universal, features of malnutrition. This article
examines recent advances in the understanding of the spectrum of celiac
disease, illustrates the impact of celiac disease on nutrition, and
describes approaches to the management of the disease.
CONTENTS continued
Growth Factors in Short Bowel Syndrome Patients 109
Palle Bekker Jeppesen
Malabsorption is a key finding in patients with short bowel syndrome.
Malabsorption of nonessential and essential nutrients, fluids, and
electrolytes, if not compensated for by increased intake, leads to
diminished body stores and subchnical and (eventually) clinical
deficiencies. After intestinal resection, adaptation (a spontaneous
progressive recovery from the malabsorptive disorder) may be evident.
This article describes selected factors responsible for the morphologic
and functional changes in the adaptive processes and presents results of
clinical trials that use either growth hormone or glucagon like peptidc 2
to facilitate a condition of hyperadaptation in short bowel patients.
Home Parenteral and Enterai Nutrition 123
John K. DiBaise and James S. Scolapio
Home parenteral and enterai nutrition (HPEN) has evolved to become
a very successful, lifesaving treatment in the management of patients
with intestinal and oral failure, respectively. Nevertheless, the provision
of HPEN remains intrusive, expensive, and continues to be associated
with significant morbidity. The management of HPEN by a nutrition
support team that optimally includes an experienced clinician, nurse
specialist, dietitian, and pharmacist reduces HPEN related morbidity
and may reduce costs associated with its use. Because clinical expertise
in the management of patients receiving HPEN is not widely available,
the referral of these patients to experienced centers for periodic
assessment should be encouraged.
Intestinal Transplantation: Current Status 145
Jonathan P. Fryer
Intestine transplant is indicated for patients with intestinal failure who
are unable to be weaned from parenteral nutrition (PN). Long term PN.
although life sustaining in many patients, can be associated with life
threatening complications including PN associated liver disease
(PNALD). Most patients are not considered for intestine transplant
until the) have developed severe PNALD and also need a liver
transplant. Overall outcomes with intestinal transplantation arc steadily
improving, and current 1 year patient survivals for intestine only
transplants are now similar to those for liver transplant. Intestinal
transplantation should be considered earlier in intestinal failure patients
who are at high risk for developing PNALD and other life threatening
complications.
CONTENTS continued
Metabolic Bone Disease in Gastrointestinal Illness 161
Susan E. Williams and Douglas L. Seidner
Metabolic bone disease is often silent, often undiagnosed, and occurs
frequently in patients with chronic gastrointestinal illnesses. Potentially
modifiable risk factors, such as malnutrition, malabsorption, prolonged
use of glucocorticoids, and a sedentary lifestyle, can lead to low bone
mass, an increased rate of bone loss, and debilitating bone disease. This
article explores common gastrointestinal illnesses that place patients at
risk for developing metabolic bone disease. Concepts are presented to
assist the practitioner in identifying patients at risk; clinical evaluation
and diagnostic test selection are discussed, and therapeutic options for
the prevention and treatment of metabolic bone disease in gastrointes¬
tinal illness are presented.
Obesity Management 191
Robert F. Kushner
Because obesity is associated with an increased risk of multiple health
problems, it is important for gastroenterologists and all health care
providers routinely to identify, evaluate, and treat patients for obesity in
the course of daily practice. Therapy for obesity always begins with
lifestyle management and may include pharmacotherapy or surgery.
Setting an initial weight loss goal of lO°/o over 6 months is a realistic
target, followed by long term management.
Index 211
|
| adam_txt |
Elsevier BEMsfiHallES«3aME^^^^^^^^^^^^^^^^^^^^B
sAUNDERs HflHHMNMBHiHMHMIH^^^H^^^^Hil^l^HliH^^^^Hii^H
Nutrition in Gastrointestinal Illness
CONTENTS VOLUME 36 « NUMBER 1 » MARCH 2007
Preface xi
Alan L. Buchman
Nutritional Assessment 1
Mark H. DeLegge and Luke M. Drake
Hospital based malnutrition continues to be an important comorbidity
affecting clinical outcomes. Knowledge of performing an appropriate
nutrition assessment and implementing a rational nutrition therapy
should be part of any patient's hospital plan of care. Familiarity with
nutrition assessment scoring systems and nutrition assessment tools
should be part of any gastroenteroiogist's expertise. Assessment of
a patient's caloric and protein needs should be part of any hospital
patient's clinical evaluation.
Complications of Parenteral Nutrition 23
Andrew Ukleja and Michelle M. Romano
Parenteral nutrition plays a vital role for patients with intestinal failure
and those who are unable to maintain oral or enterai nutrition alone.
Parenteral nutrition has been shown to improve clinical outcome in
patients with malnutrition and intestinal tract dysfunction. The use of
parenteral nutrition is not without risk of serious complications.
Parenteral nutrition complications can be divided into mechanical
related to vascular access, septic, and metabolic. This article provides
a review on the short and long term complications of parenteral
nutrition and their management.
Prebiotics, Probiotics, and Dietary Fiber
in Gastrointestinal Disease 47
Jacqueline Park and Martin H. Floch
Microecology of the gastrointestinal tract is the physiologic basis for the
effect of dietary' fiber, prebiotics and probiotics on the host. The ecology
consists of the gastrointestinal tract, primarily the intestines, the foods
that are fed into the tract, and the flora living within. Within this
ecology, normal flora and probiotics, ferment dietary fiber and
prebiotics to produce short chain fatty acids and substances that are
absorbed and effect the host at the intestinal level and systemically. In
CONTENTS continued
this review, we will discuss the effects of prebiotics, probiotics and
dietary fiber in gastrointestinal disorders and diseases.
Nutrition Support in Acute Pancreatitis 65
Stephen A. McClave
The benefit of early enterai nutrition (EN) for the disease process and
for patient outcome in severe acute pancreatitis is dramatic. A narrow
window of opportunity exists during which there is potential for EN to
decrease disease severity and reduce overall complications. Most
patients with severe pancreatitis tolerate enterai feeds. Any signs of
symptom exacerbation or increasing inflammation in response to EN
may be ameliorated by subtle adjustments in the feeding strategy. In
this manner, provision of EN represents primary therapy in the
management of the patient with acute pancreatitis and is emerging as
the gold standard of therapy in nutrition support for this disease
process.
Food Allergies and Eosinophilic Gastrointestinal Illness 75
Nirmala Gonsalves
Eosinophilic gastrointestinal disorders are characterized by eosinophilic
infiltration and inflammation of the gastrointestinal tract in the absence
of previously identified causes of eosinophilia, such as parasitic
infections, malignancy, collagen vascular diseases, drug sensitivities,
and inflammatory bowel disease. These disorders include eosinophilic
esophagitis, eosinophilic gastroenteritis, eosinophilic enteritis, and
eosinophilic colitis. This article focuses mainly on eosinophilic
esophagitis and eosinophilic gastroenteritis.
Nutritional Deficiencies in Celiac Disease 93
Susan H. Barton, Darlene G. Kelly, and Joseph A. Murray
Celiac disease is characterized by small bowel enteropathy, precipitated
in genetically susceptible individuals by the ingestion of "gluten," which
is a term used to encompass the storage proteins of wheat, rye, and
barley. Although the intestine heals with removal of gluten from die
diet, the intolerance is permanent and the damage recurs if gluten is
reintroduced. This damage causes a wide variety of consequence
including maldigestion and malabsorption, resulting in the character¬
istic, aldiough not universal, features of malnutrition. This article
examines recent advances in the understanding of the spectrum of celiac
disease, illustrates the impact of celiac disease on nutrition, and
describes approaches to the management of the disease.
CONTENTS continued
Growth Factors in Short Bowel Syndrome Patients 109
Palle Bekker Jeppesen
Malabsorption is a key finding in patients with short bowel syndrome.
Malabsorption of nonessential and essential nutrients, fluids, and
electrolytes, if not compensated for by increased intake, leads to
diminished body stores and subchnical and (eventually) clinical
deficiencies. After intestinal resection, adaptation (a spontaneous
progressive recovery from the malabsorptive disorder) may be evident.
This article describes selected factors responsible for the morphologic
and functional changes in the adaptive processes and presents results of
clinical trials that use either growth hormone or glucagon like peptidc 2
to facilitate a condition of hyperadaptation in short bowel patients.
Home Parenteral and Enterai Nutrition 123
John K. DiBaise and James S. Scolapio
Home parenteral and enterai nutrition (HPEN) has evolved to become
a very successful, lifesaving treatment in the management of patients
with intestinal and oral failure, respectively. Nevertheless, the provision
of HPEN remains intrusive, expensive, and continues to be associated
with significant morbidity. The management of HPEN by a nutrition
support team that optimally includes an experienced clinician, nurse
specialist, dietitian, and pharmacist reduces HPEN related morbidity
and may reduce costs associated with its use. Because clinical expertise
in the management of patients receiving HPEN is not widely available,
the referral of these patients to experienced centers for periodic
assessment should be encouraged.
Intestinal Transplantation: Current Status 145
Jonathan P. Fryer
Intestine transplant is indicated for patients with intestinal failure who
are unable to be weaned from parenteral nutrition (PN). Long term PN.
although life sustaining in many patients, can be associated with life
threatening complications including PN associated liver disease
(PNALD). Most patients are not considered for intestine transplant
until the)' have developed severe PNALD and also need a liver
transplant. Overall outcomes with intestinal transplantation arc steadily
improving, and current 1 year patient survivals for intestine only
transplants are now similar to those for liver transplant. Intestinal
transplantation should be considered earlier in intestinal failure patients
who are at high risk for developing PNALD and other life threatening
complications.
CONTENTS continued
Metabolic Bone Disease in Gastrointestinal Illness 161
Susan E. Williams and Douglas L. Seidner
Metabolic bone disease is often silent, often undiagnosed, and occurs
frequently in patients with chronic gastrointestinal illnesses. Potentially
modifiable risk factors, such as malnutrition, malabsorption, prolonged
use of glucocorticoids, and a sedentary lifestyle, can lead to low bone
mass, an increased rate of bone loss, and debilitating bone disease. This
article explores common gastrointestinal illnesses that place patients at
risk for developing metabolic bone disease. Concepts are presented to
assist the practitioner in identifying patients at risk; clinical evaluation
and diagnostic test selection are discussed, and therapeutic options for
the prevention and treatment of metabolic bone disease in gastrointes¬
tinal illness are presented.
Obesity Management 191
Robert F. Kushner
Because obesity is associated with an increased risk of multiple health
problems, it is important for gastroenterologists and all health care
providers routinely to identify, evaluate, and treat patients for obesity in
the course of daily practice. Therapy for obesity always begins with
lifestyle management and may include pharmacotherapy or surgery.
Setting an initial weight loss goal of lO°/o over 6 months is a realistic
target, followed by long term management.
Index 211 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author_GND | (DE-588)137986106 |
| building | Verbundindex |
| bvnumber | BV022468894 |
| ctrlnum | (OCoLC)145743502 (DE-599)HBZHT015139161 |
| dewey-full | 616.330654 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.330654 |
| dewey-search | 616.330654 |
| dewey-sort | 3616.330654 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01456nam a2200361 cb4500</leader><controlfield tag="001">BV022468894</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150113 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">070618s2007 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1416039112</subfield><subfield code="9">1-4160-3911-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781416039112</subfield><subfield code="9">978-1-4160-3911-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)145743502</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)HBZHT015139161</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-29</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.330654</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nutrition in gastrointestinal illness</subfield><subfield code="c">guest ed. Alan L. Buchman</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia [u.a.]</subfield><subfield code="b">Saunders</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIII, 218 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Gastroenterology clinics of North America</subfield><subfield code="v">36,1</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gastrointestinal Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gastrointestinal Diseases</subfield><subfield code="x">diet therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gastrointestinal system</subfield><subfield code="x">Diseases</subfield><subfield code="x">Nutritional aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nutrition Disorders</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buchman, Alan L.</subfield><subfield code="d">1960-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)137986106</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Gastroenterology clinics of North America</subfield><subfield code="v">36,1</subfield><subfield code="w">(DE-604)BV000613725</subfield><subfield code="9">36,1</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015676419&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015676419</subfield></datafield></record></collection> |
| id | DE-604.BV022468894 |
| illustrated | Illustrated |
| index_date | 2024-07-02T17:43:43Z |
| indexdate | 2024-07-09T20:58:15Z |
| institution | BVB |
| isbn | 1416039112 9781416039112 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-015676419 |
| oclc_num | 145743502 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-29 |
| owner_facet | DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-29 |
| physical | XIII, 218 S. Ill., graph. Darst. |
| publishDate | 2007 |
| publishDateSearch | 2007 |
| publishDateSort | 2007 |
| publisher | Saunders |
| record_format | marc |
| series | Gastroenterology clinics of North America |
| series2 | Gastroenterology clinics of North America |
| spelling | Nutrition in gastrointestinal illness guest ed. Alan L. Buchman Philadelphia [u.a.] Saunders 2007 XIII, 218 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Gastroenterology clinics of North America 36,1 Gastrointestinal Diseases Gastrointestinal Diseases diet therapy Gastrointestinal system Diseases Nutritional aspects Nutrition Disorders Buchman, Alan L. 1960- Sonstige (DE-588)137986106 oth Gastroenterology clinics of North America 36,1 (DE-604)BV000613725 36,1 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015676419&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Nutrition in gastrointestinal illness Gastroenterology clinics of North America Gastrointestinal Diseases Gastrointestinal Diseases diet therapy Gastrointestinal system Diseases Nutritional aspects Nutrition Disorders |
| title | Nutrition in gastrointestinal illness |
| title_auth | Nutrition in gastrointestinal illness |
| title_exact_search | Nutrition in gastrointestinal illness |
| title_exact_search_txtP | Nutrition in gastrointestinal illness |
| title_full | Nutrition in gastrointestinal illness guest ed. Alan L. Buchman |
| title_fullStr | Nutrition in gastrointestinal illness guest ed. Alan L. Buchman |
| title_full_unstemmed | Nutrition in gastrointestinal illness guest ed. Alan L. Buchman |
| title_short | Nutrition in gastrointestinal illness |
| title_sort | nutrition in gastrointestinal illness |
| topic | Gastrointestinal Diseases Gastrointestinal Diseases diet therapy Gastrointestinal system Diseases Nutritional aspects Nutrition Disorders |
| topic_facet | Gastrointestinal Diseases Gastrointestinal Diseases diet therapy Gastrointestinal system Diseases Nutritional aspects Nutrition Disorders |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015676419&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000613725 |
| work_keys_str_mv | AT buchmanalanl nutritioningastrointestinalillness |